Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2017 - 2024)

Neurocrine Biosciences' Interest Coverage Ratio history spans 8 years, with the latest figure at 90.27 for Q1 2024.

  • For Q1 2024, Interest Coverage Ratio rose 186.95% year-over-year to 90.27; the TTM value through Dec 2024 reached 518.64, up 850.87%, while the annual FY2023 figure was 54.54, 55.53% up from the prior year.
  • Interest Coverage Ratio reached 90.27 in Q1 2024 per NBIX's latest filing, down from 136.64 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 136.64 in Q4 2023 to a low of 103.82 in Q1 2023.
  • Average Interest Coverage Ratio over 5 years is 31.65, with a median of 9.23 recorded in 2020.
  • Peak YoY movement for Interest Coverage Ratio: surged 1809.09% in 2022, then tumbled 8807.33% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 9.21 in 2020, then tumbled by 159.75% to 5.5 in 2021, then soared by 1809.09% to 94.0 in 2022, then surged by 45.36% to 136.64 in 2023, then plummeted by 33.93% to 90.27 in 2024.
  • Per Business Quant, the three most recent readings for NBIX's Interest Coverage Ratio are 90.27 (Q1 2024), 136.64 (Q4 2023), and 128.36 (Q3 2023).